BNP Paribas Financial Markets
MBIO icon

BNP Paribas Financial Markets’s Mustang Bio MBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
6
– – ﹤0.01% 5883
2026
Q1 		$4 Hold
6
– – ﹤0.01% 5782
2025
Q4 		$6 Hold
6
– – ﹤0.01% 5704
2025
Q3 		$9 Hold
6
– – ﹤0.01% 5522
2025
Q2 		$6 Hold
6
– – ﹤0.01% 5416
2025
Q1 		$8 Sell
6
-1
-14% -$4 ﹤0.01% 5345
2024
Q4 		$60 Buy
+7
New +$77 ﹤0.01% 5309
2023
Q1 		– Sell
-12
Closed -$3.42K – 3975
2022
Q4 		$3.42K Buy
12
+3
+33% +$1.02K ﹤0.01% 3692
2022
Q3 		$3.33K Sell
9
-63
-88% -$29.2K ﹤0.01% 4293
2022
Q2 		$31.4K Buy
72
+59
+454% +$32.7K ﹤0.01% 3647
2022
Q1 		$9.5K Sell
13
-24
-65% -$19.7K ﹤0.01% 3810
2021
Q4 		$45.9K Buy
37
+16
+76% +$25.8K ﹤0.01% 3757
2021
Q3 		$42.7K Buy
21
+11
+110% +$23.6K ﹤0.01% 3554
2021
Q2 		$24.9K Buy
10
+1
+11% +$2.45K ﹤0.01% 3476
2021
Q1 		$22.3K Sell
9
-4
-31% -$11.9K ﹤0.01% 3740
2020
Q4 		$35.6K Buy
13
+5
+63% +$12K ﹤0.01% 3693
2020
Q3 		$19.8K Buy
8
+6
+300% +$14.8K ﹤0.01% 3835
2020
Q2 		$4.8K Sell
2
-10
-83% -$23.4K ﹤0.01% 4020
2020
Q1 		$23.2K Buy
12
+7
+140% +$17.9K ﹤0.01% 3865
2019
Q4 		$16.1K Buy
5
+1
+25% +$2.29K ﹤0.01% 4052
2019
Q3 		$10.5K Buy
4
+1
+33% +$2.74K ﹤0.01% 4143
2019
Q2 		$7K Sell
3
-2
-40% -$5.71K ﹤0.01% 4184
2019
Q1 		$11.7K Buy
+5
New +$14.2K ﹤0.01% 4010
2018
Q4 		– Sell
-1
Closed -$3.04K – 3932
2018
Q3 		$3.24K Hold
1
– – ﹤0.01% 4188
2018
Q2 		$3.75K Buy
+1
New +$6.32K ﹤0.01% 4163

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $743M AUM 25.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BNP Paribas Financial Markets's MBIO Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Mustang Bio (MBIO) position steady in Q2 2026 at 6 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5883.

BNP Paribas Financial Markets first reported a position in MBIO in Q2 2018 and has held it in 25 quarters since. The position peaked at $45.9K in Q4 2021. 16 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • BNP Paribas Financial Markets held 6 shares of Mustang Bio worth $4 as of Q2 2026.
  • BNP Paribas Financial Markets left its Mustang Bio share count unchanged in Q2 2026.
  • Mustang Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5883 holding.
  • BNP Paribas Financial Markets first reported a position in Mustang Bio in Q2 2018 and has held it in 25 quarters since.
  • BNP Paribas Financial Markets's Mustang Bio position peaked at $45.9K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.